These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2776821)

  • 1. Sustained-release and instant-release verapamil in treatment of angina pectoris.
    Jespersen CM; Klitgaard NA; Nielsen H; Hansen JF
    Eur J Clin Pharmacol; 1989; 36(6):625-7. PubMed ID: 2776821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained-release verapamil and nifedipine in exercise-induced angina pectoris.
    Foale RA; Vandenburg MJ
    Eur Heart J; 1992 Feb; 13(2):256-60. PubMed ID: 1555625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained release verapamil, a once daily preparation: objective evaluation using exercise testing, ambulatory monitoring and blood levels in patients with stable angina.
    Kohli RS; Rodrigues EA; Hughes LO; Lahiri A; Raftery EB
    J Am Coll Cardiol; 1987 Mar; 9(3):615-21. PubMed ID: 3102585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of sustained-release verapamil in chronic stable angina pectoris.
    Weiner DA; Klein MD; Cutler SS
    Am J Cardiol; 1987 Feb; 59(4):215-8. PubMed ID: 3544792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of sustained release verapamil versus atenolol for 24 h protection from exercise-induced angina pectoris.
    Hopkinson ND; Hui KP; Smith MP; Hollinrake K
    Eur Heart J; 1991 Dec; 12(12):1273-7. PubMed ID: 1778191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind randomised placebo-controlled dose-efficacy study of sustained release verapamil in chronic stable angina.
    Gibbs JS; McAlpine HM; Wright C; McLenachan JM; Sparrow J; Sutton G; Dargie HJ; Fox KM
    Int J Cardiol; 1991 Jun; 31(3):281-6. PubMed ID: 1879977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a transdermal patch system containing nitroglycerin on exercise tolerance in patients with angina pectoris. Double-blind, placebo controlled, comparison with slow-release nifedipine and verapamil.
    Gibelli G; Negrini M; Mazzocchi F; Prina L; Pollavini P; De Ponti C
    G Ital Cardiol; 1986 Nov; 16(11):904-8. PubMed ID: 3104124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris.
    Cutler NR; Anders RJ; Jhee SS; Sramek JJ; Awan NA; Bultas J; Lahiri A; Woroszylska M
    Am J Cardiol; 1995 Jun; 75(16):1102-6. PubMed ID: 7762493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized double-blind comparison of the effects of isosorbide dinitrate retard, verapamil sustained-release, and their combination on myocardial ischemic episodes.
    Friedensohn A; Meshulam R; Schlesinger Z
    Cardiology; 1991; 79 Suppl 2():31-40. PubMed ID: 1760827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An objective evaluation of once-daily sustained-release verapamil (480 mg) in chronic stable angina.
    Rodrigues EA; DasGupta P; Hains AD; Raftery EB
    Eur J Clin Pharmacol; 1988; 34(5):531-2. PubMed ID: 3060361
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of conventional and sustained-release verapamil in stable angina pectoris.
    Pellinen TJ; Lukkala K; Sundberg S; Heikkilä J; Frick MH
    Ann Med; 1992 Feb; 24(1):49-53. PubMed ID: 1349486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new sustained-release formulation of verapamil in the treatment of hypertension.
    Midtbo KA; Hals O; Lauve O
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):125S-132S. PubMed ID: 3540222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of angina pectoris and hypertension with sustained-release calcium channel-blocking drugs.
    Klein MD; Weiner DA
    Circulation; 1987 Jun; 75(6 Pt 2):V110-3. PubMed ID: 3552310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-daily verapamil--an objective evaluation in stable angina pectoris using treadmill exercise testing.
    Raftery EB
    Br J Clin Pract Suppl; 1985 Jun; 42():17-23. PubMed ID: 3929824
    [No Abstract]   [Full Text] [Related]  

  • 16. Verapamil administered twice daily in stable angina pectoris.
    Tan AT; Quek S
    Chest; 1984 Jan; 85(1):55-8. PubMed ID: 6360575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the efficacy of verapamil in slow-release preparations in the treatment of stable exertion angina].
    Scrutinio D; Lagioia R; De Toma L; Mangini S; Accettura D; De Nicolò M
    Cardiologia; 1982 Oct; 27(10):963-71. PubMed ID: 6927458
    [No Abstract]   [Full Text] [Related]  

  • 18. Verapamil in chronic stable angina. A controlled study with computerized multistage treadmill exercise.
    Subramanian VB; Lahiri A; Paramasivan R; Raftery EB
    Lancet; 1980 Apr; 1(8173):841-4. PubMed ID: 6103208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian variation in the pharmacokinetics of verapamil.
    Jespersen CM; Frederiksen M; Hansen JF; Klitgaard NA; Sørum C
    Eur J Clin Pharmacol; 1989; 37(6):613-5. PubMed ID: 2612558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentration--response relationship of verapamil in the treatment of angina pectoris.
    Anderson P; Bondesson U; Sylvén C; Aström H
    J Cardiovasc Pharmacol; 1982; 4(4):609-14. PubMed ID: 6181335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.